期刊文献+

皮肌炎患者血清中细胞因子检测及临床意义 被引量:6

Detection of serum cytokines in patients with dermatomyositis and their clinical significance
原文传递
导出
摘要 目的 探讨皮肌炎(DM)和临床无肌病性皮肌炎(CADM)患者血清细胞因子水平与疾病活动,特别是与皮损和肺间质病变之间的联系。方法 采用酶联免疫吸附测定和流式微珠阵列法检测40例DM/CADM患者血清中白细胞介素(IL)2、IL-4、IL-6、IL-10、IL-17A、IL-18、肿瘤坏死因子、γ干扰素8种细胞因子水平,分析细胞因子与皮损、炎症指标和肺间质病变严重程度的关系。结果 ①DM/CADM患者血清中,IL-6(37.8 ± 45.8 pg/ml)、IL-10(16.1 ± 7.2 pg/ml)和IL-18(492.0 ± 193.1 pg/ml)水平显著高于健康对照组IL-6(12.0 ± 2.7 pg/ml)、IL-10(7.7 ± 1.4 pg/ml)和IL-18(191.1 ± 39.2 pg/ml)水平,均P 〈0.001。其他5种细胞因子与健康对照组比较,差异无统计学意义;②红细胞沉降率升高患者的血清IL-6水平(49.7 ± 46.8 pg/ml)显著高于红细胞沉降率正常患者(29.1 ± 45.4 pg/ml),P = 0.008;C反应蛋白升高患者的血清IL-6(68.7 ± 59.7 pg/ml)和IL-18(635.1 ± 232.8 pg/ml)水平显著高于C反应蛋白正常患者(IL-6为30.6 ± 40.3 pg/ml,P = 0.013;IL-18为440.2 ± 164.7 pg/ml,P = 0.020);乳酸脱氢酶升高患者的IL-10(18.4 ± 6.9 pg/ml)、IL-17A(19.6 ± 6.7 pg/ml)和IL-18(529.4 ± 197.2 pg/ml)显著高于乳酸脱氢酶正常患者(IL-10为10.7 ± 4.8 pg/ml,P 〈 0.001;IL-17A为11.4 ± 6.6 pg/ml,P = 0.001;IL-18为404.9 ± 158.0 pg/ml,P = 0.037);肌酸激酶升高组与肌酸激酶正常组之间细胞因子水平比较,差异无统计学意义;③具有Gottron丘疹/征的患者血清IL-18水平(513.7 ± 187.2 pg/ml)显著高于无Gottron丘疹/征的患者(297.1 ± 140.4 pg/ml),P 〈 0.05;④DM/CADM伴肺间质病变的患者血清IL-10(18.0 ± 6.7 pg/ml)和IL-18水平(552.3 ± 192.8 pg/ml)显著高于不伴肺间质病变者(IL-10为11.6 ± 6.5 pg/ml,IL-18为351.4 ± 101.0 pg/ml),P = 0.001。结论 皮肌炎患者血清IL-6、IL-10、IL-18等� Objective To explore the association of serum cytokine levels with disease activity in patients with dermatomyositis(DM)and clinically amyopathic dermatomyositis(CADM), especially their association with skin lesions and interstitial lung disease (ILD). Methods Enzyme-linked immunosorbent assay (ELISA) and cytometric beads array (CBA)were performed to detect the serum levels of interleukin (IL)-2, IL-4, IL-6, IL-10, IL-17A, IL-18, tumor necrosis factor (TNF) and interferon (IFN)-γ in 40 patients with DM or CADM, as well as in 16 health checkup examinees (healthy control group). Then, the association of serum cytokine levels with skin lesions, inflammatory biomarkers and severity of ILD was analyzed. Results The patients with DM/CADM showed significantly higher serum levels of IL-6 (37.8 ± 45.8 pg/ml), IL-10 (16.1 ± 7.2 pg/ml) and IL-18 (492.0 ± 193.1 pg/ml) compared with the healthy controls (12.0 ± 2.7 pg/ml, 7.7 ± 1.4 pg/ml, 191.1 ± 39.2 pg/ml, respectively, all P 〈 0.001), and there were no significant differences in the serum levels of the other 5 cytokines between the above 2 groups. The serum level of IL-6 was significantly higher in patients with elevated erythrocyte sedimentation rate (ESR) than in those with normal ESR (49.7 ± 46.8 pg/ml vs. 29.1 ± 45.4 pg/ml, P = 0.008). The patients with raised C-reactive protein (CRP) levels showed significantly higher serum levels of IL-6 (68.7 ± 59.7 pg/ml) and IL-18 (635.1 ± 232.8 pg/ml) compared with those with normal CRP levels (IL-6: 30.6 ± 40.3 pg/ml, P = 0.013;IL-18: 440.2 ± 164.7 pg/ml, P = 0.020). Moreover, the patients with elevated levels of lactate dehydrogenase (LDH) showed significantly higher serum levels of IL-10 (18.4 ± 6.9 pg/ml), IL-17A (19.6 ± 6.7 pg/ml) and IL-18 (529.4 ± 197.2 pg/ml) compared with those with normal LDH levels (IL-10: 10.7 ± 4.8 pg/ml, P 〈 0.001; IL-17A: 11.4 ± 6.6 pg/ml, P = 0.001; IL-18: 404.9 ± 158.0 pg
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2018年第1期34-38,共5页 Chinese Journal of Dermatology
基金 国家自然科学基金(81573037) 国家临床重点专科建设项目(2012649) 上海市科委医学引导类项目(134119a6100)
关键词 皮肌炎 细胞因子类 肺疾病 间质性 临床无肌病性皮肌炎 Dermatomyositis Cytokines Lung Diseases, Interstitial Interstitial lung disease Clinically amyopathic dermatomyositis
  • 相关文献

参考文献4

二级参考文献49

  • 1Sontheimer RD. Would a new name hasten the acceptance of amyopathie dermatomyositis (dermatomyositis sins myositis) as adistinctive subset within the idiopathic inflammatory dermatomy- opathies spectrum of clinical illness? J Am Acad Dermatol, 2002, 46(4): 626-636. 被引量:1
  • 2Stonecipher MR, Jorizzo JL, White WL, et al. Cutaneous changes of dermatomyositis in patients with normal muscle enzymes: der- matomyositis sine myositis? J Am Acad Dermatol, 1993, 28 (6): 951-956. 被引量:1
  • 3Sontheimer RD. Cutaneous features of classic dermatomyositis and amyopathic dermatomyositis. Curr Opin Rheumatol, 1999, 11 (6): 475 -482. 被引量:1
  • 4Cao H, Parikh TN, Zheng J. Amyopathic dermatomyositis or der- matomyositis-like skin disease: retrospective review of 16 cases with amyopathic dermatomyositis. Clin Rheumatol, 2009, 28(8): 979-984. 被引量:1
  • 5Airio A, Kautiainen H, Hakala M. Prognosis and mortality of polymyositis and dermatomyositis patients. Clin Rheumatol, 2006, 25(2): 234-239. 被引量:1
  • 6Sato S, Hirakata M, Kuwana M, et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum, 2005, 52 (5): 1571-1576. 被引量:1
  • 7Sato S, Hoshino K, Satoh T, et al. RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Associa- tion with rapidly progressive interstitial lung disease. Arthritis Rheum, 2009, 60(7): 2193-2200. 被引量:1
  • 8Nakashima R, Imura Y, Kobayashi S, et al. The RIG-I-like receptor IFIHI/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatology (Oxford), 2010, 49(3): 433-440. 被引量:1
  • 9Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Eng1 J Med, 1975, 292(7): 344-347. 被引量:1
  • 10Euwer RL, Sontheimer RD. Amyopathic dermatomyositis: a review. J Invest Dermatol, 1993, 100(1): 124S-127S. 被引量:1

共引文献28

同被引文献70

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部